• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination".

作者信息

Phan Hiep, Hayney Mary S, Caldera Freddy

机构信息

Division of Internal Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

School of Pharmacy, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

出版信息

Inflamm Bowel Dis. 2023 Mar 1;29(3):e8-e9. doi: 10.1093/ibd/izad006.

DOI:10.1093/ibd/izad006
PMID:36715158
Abstract
摘要

相似文献

1
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination".对《接受抗TNF治疗的炎症性肠病患者与COVID-19疫苗接种》的回复
Inflamm Bowel Dis. 2023 Mar 1;29(3):e8-e9. doi: 10.1093/ibd/izad006.
2
Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence.接受抗 TNF 治疗的炎症性肠病患者与 COVID-19 疫苗接种：通信
Inflamm Bowel Dis. 2023 Mar 1;29(3):e7. doi: 10.1093/ibd/izac257.
3
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease.抗肿瘤坏死因子治疗与炎症性肠病患者对 SARS-CoV-2 疫苗的体液免疫应答减弱相关。
Vaccine. 2023 Jun 13;41(26):3862-3871. doi: 10.1016/j.vaccine.2023.05.012. Epub 2023 May 8.
4
Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON].炎症性肠病患者对 COVID-19 疫苗的血清学反应降低，而 TNF 抑制剂治疗进一步降低；VARIATION 研究的早期结果 [针对 SARS-COV-2 免疫的 IBD 反应变异性]。
J Crohns Colitis. 2022 Sep 8;16(9):1354-1362. doi: 10.1093/ecco-jcc/jjac029.
5
Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.儿童炎症性肠病患者感染或接种SARS-CoV-2后的血清转化
Inflamm Bowel Dis. 2021 Oct 20;27(11):1862-1864. doi: 10.1093/ibd/izab194.
6
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.炎症性肠病患者对新型冠状病毒mRNA疫苗的体液免疫反应
Gastroenterology. 2021 Oct;161(4):1340-1343.e2. doi: 10.1053/j.gastro.2021.06.016. Epub 2021 Jun 15.
7
COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives.炎症性肠病患者的新冠疫苗：特殊性与未来展望
J Crohns Colitis. 2022 Sep 8;16(9):1343-1344. doi: 10.1093/ecco-jcc/jjac042.
8
Response to COVID-19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose.炎症性肠病患者对 COVID-19 疫苗的反应降低，但增加剂量可改善。
J Gastroenterol Hepatol. 2023 Jan;38(1):44-51. doi: 10.1111/jgh.16001. Epub 2022 Sep 21.
9
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy.接受抗TNF治疗的炎症性肠病儿科患者对BNT162b2新冠病毒疫苗的抗体反应。
Gut. 2022 Sep;71(9):1922-1924. doi: 10.1136/gutjnl-2021-326196. Epub 2021 Nov 23.
10
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.肠道微生物组和代谢组与免疫抑制性炎症性肠病患者 COVID-19 疫苗诱导的抗体反应减弱有关。
EBioMedicine. 2023 Feb;88:104430. doi: 10.1016/j.ebiom.2022.104430. Epub 2023 Jan 10.